TEVA PHARMACEUTICAL INDUSTRIES LIMITED

(TEVA)
  Report
Real-time Estimate Cboe BZX  -  10:38 2022-08-19 am EDT
10.43 USD   +0.82%
08/17Pharmacies ordered to pay $650.6 million to Ohio counties in opioid case
RE
08/05BofA Securities Upgrades Teva Pharmaceutical Industries to Buy From Neutral, Adjusts Price Target to $13 From $10
MT
08/03TEVA PHARMACEUTICAL INDUSTRIES : Form 3-initial statement of beneficial ownership of securities-eric hughes
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/15/2022 08/16/2022 08/17/2022 08/18/2022 08/19/2022 Date
11.2(c) 11.03(c) 10.01(c) 10.45(c) 10.37 Last
9 725 000 12 774 915 37 522 489 18 981 549 2 982 381 Volume
-0.09% -1.52% -9.25% +4.40% +0.29% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 15 331 M - -
Net income 2022 -487 M - -
Net Debt 2022 19 346 M - -
P/E ratio 2022 -23,0x
Yield 2022 -
Sales 2023 15 599 M - -
Net income 2023 1 041 M - -
Net Debt 2023 17 099 M - -
P/E ratio 2023 18,4x
Yield 2023 -
Capitalization 11 483 M 11 483 M -
EV / Sales 2022 2,01x
EV / Sales 2023 1,83x
Nbr of Employees 35 346
Free-Float 89,8%
More Financials
Company
Teva Pharmaceutical Industries Limited is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active... 
Sector
Pharmaceuticals
Calendar
11/03Earnings Release
More about the company
Ratings of Teva Pharmaceutical Industries Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED
08/17Pharmacies ordered to pay $650.6 million to Ohio counties in opioid case
RE
08/05BofA Securities Upgrades Teva Pharmaceutical Industries to Buy From Neutral, Adjusts Pr..
MT
08/03TEVA PHARMACEUTICAL INDUSTRIES : Form 3-initial statement of beneficial ownership of secur..
PU
07/29States reach deal over marketing, safety of generic opioids
AQ
07/29PUMP / DUMP #39 : This week's gainers and losers
MS
07/29AbbVie sets aside $2 billion to settle U.S. opioid claims
RE
07/29INSIDER SELL : Teva Pharmaceutical Industries
MT
07/27Spotify, Alphabet rise; Kraft Heinz, Garmin fall
AQ
07/27TEVA PHARMACEUTICAL INDUSTRIES LTD MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL C..
AQ
07/27SECTOR UPDATE : Health Care Stocks Recover in Late Wednesday Trading
MT
07/27Health Care Edges Higher on Cyclical Bias - Health Care Roundup
DJ
07/27Teva Pharmaceutical Industries Up Over 23%, on Pace for Record Percent Increase -- Data..
DJ
07/27Teva Pharmaceutical Sharers Rise As Company Agrees on Financial Terms for Nationwide Op..
MT
07/27GLOBAL MARKETS LIVE : Adidas, Alphabet, Chipotle, Spotify, Shopify...
MS
07/27Teva Pharm sees return to growth post-opioid settlement
RE
More news
News in other languages on TEVA PHARMACEUTICAL INDUSTRIES LIMITED
07/29PUMP / DUMP #68 : Les Tops & Flops de la semaine
07/29AbbVie met de côté 2 milliards de dollars pour régler les plaintes relatives aux opioïd..
07/29VENTE D'INITIÉS : Teva Pharmaceutical Industries
07/27MISE À JOUR SECTORIELLE : Les actions du secteur de la santé se redressent en fin de journ..
07/27Les actions de Teva Pharmaceutical augmentent alors que la société s'accorde sur les co..
More news
Analyst Recommendations on TEVA PHARMACEUTICAL INDUSTRIES LIMITED
More recommendations
Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Duration : Period :
Teva Pharmaceutical Industries Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 10,34 $
Average target price 10,56 $
Spread / Average Target 2,08%
EPS Revisions
Managers and Directors
Kåre Schultz President, Chief Executive Officer & Director
Eli Kalif Chief Financial Officer & Executive Vice President
Sol J. Barer Chairman
Eric A. Hughes Chief Medical Officer, Executive VP-Global R&D
Eric Drapé SVP-Technical Operations Steriles & Respiratory
Sector and Competitors
1st jan.Capi. (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED29.09%11 483
JOHNSON & JOHNSON-2.51%440 598
ELI LILLY AND COMPANY14.66%301 034
PFIZER, INC.-17.73%276 521
ROCHE HOLDING AG-16.47%273 077
ABBVIE INC.4.35%250 080